Home Page PIONEERING CELL & ANTIBODY-BASED CANCER THERAPEUTICS NEWS 'Alphageneron Announces Successful Completion of Pre-IND Meeting for ENKASTIMâ„¢ NK Cell Therapy with the US FDA on September 27 2021' Harvard Square, One Mifflin Place, Suite 400Cambridge, MA 02138, USA